Back to News
News

Semax: What the Research Shows

03 April 2026By Pure Chems Research Team 1 min read
Semax: What the Research Shows

Research Use Only: This article summarises published scientific literature for laboratory and research audiences. It is not medical advice, and Semax is not approved for human or veterinary use in this context.

What is Semax?

Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10) with an added stabilising sequence. It is studied in the neuroscience research literature and has a research history particularly in Russian institutions.

Where Semax sits in the research literature

The evidence base includes animal and cell studies exploring neuroprotection and neurotrophic signalling, as well as some clinical research. Laboratory findings should not be extrapolated to people.

Reported areas of preclinical interest

  • BDNF signalling: studied for effects on brain-derived neurotrophic factor expression in models.
  • Neuroprotection: examined in cell-stress and cognition research paradigms.

Why the “research use only” label matters

Semax is supplied as a research material and is intended strictly for laboratory and scientific research, not for human or veterinary consumption.

Handling and storage

Store lyophilised peptide cool, dry and away from light, and refrigerate reconstituted solution, using it within the indicated stability window. Follow the documentation supplied with each batch.

Frequently asked questions

What is Semax studied for?

It is studied in laboratory neuroscience models, including neurotrophic-factor and neuroprotection research.

Is Semax approved for human use?

It is supplied as a research material only and is not intended for human or veterinary use.

Key takeaways

Semax is a synthetic ACTH-derived peptide studied in preclinical neuroscience research. It is a research material only. Review the Semax research product.

References

References sourced via PubMed.

  1. Gusev EI, Martynov MY, Kostenko EV, et al. The efficacy of semax in the treatment of patients at different stages of ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(3 Pt 2):61-68. DOI · PubMed 29798983.

Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.

Research-grade compounds, verified purity

Every batch ships with a Certificate of Analysis. Explore the full PureChems catalog.

Browse the catalog